|Articles|September 23, 2022

AJMC® in the Press, September 23, 2022

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by MIT Technology Review referenced a study published in the January 2019 Health Information Technology special issue of The American Journal of Managed Care^®. The study, “Drivers of Health Information Exchange Use During Postacute Care Transitions,” showed that health information exchange offers significant potential to address unmet informational needs during transitions between hospitals and skilled nursing facilities, but workflow barriers and design limitations currently limit its value.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

AJMC® in the Press, September 23, 2022

Related Content

Science Fiction Made Real: Kerry Rogers, MD, on How CAR T Works

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch

Global HepB3 Coverage Reaches 81.8%, but Regional Gaps Persist

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

AJMC® in the Press, September 23, 2022

Related Content

Science Fiction Made Real: Kerry Rogers, MD, on How CAR T Works

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch

Global HepB3 Coverage Reaches 81.8%, but Regional Gaps Persist

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial